Calcium and phosphate concentrations and future development of type 2 diabetes: The Insulin Resistance Atherosclerosis Study

Diabetologia

Volumn 57, Issue 7, 2014, Pages 1366-1374

  Lorenzo, Carlos ^a   Hanley, Anthony J ^b,c,d   Rewers, Marian J ^e   Haffner, Steven M ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical science; Epidemiology; Human; Insulin sensitivity and resistance; Pathogenic mechanisms; Prediction and prevention of type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; GLUCOSE; PHOSPHATE;

ADULT; AFRICAN AMERICAN; ARTICLE; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISPANIC; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATHOPHYSIOLOGY; PHOSPHATE METABOLISM; PRIORITY JOURNAL; ATHEROSCLEROSIS; BLOOD; DIABETES MELLITUS, TYPE 2; INCIDENCE; MIDDLE AGED; PHYSIOLOGY;

ATHEROSCLEROSIS; CALCIUM; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; PHOSPHATES;

EID: 84903551039     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3241-9     Document Type: Article

References (50)

1. Leiffsson BG, Ahren B (1996) Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 81:2149-2153
2. Håglin L, Törnkvist B, Bäckman L (2007) Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium. Acta Diabetol 44:138-143
3. Walsh JP, Divitini ML, Knuiman MW (2013) Plasma calcium as a predictor of cardiovascular disease in a community-based cohort. Clin Endocrinol (Oxf) 78:852-857
4. Jorde R, Schirmer H, Njølstad I et al (2013) Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study. Eur J Epidemiol 28:569-578
5. Andersson P, Rydberg E, Willenheimer R (2004) Primary hyperparathyroidism and heart disease: a review. Eur Heart J 25:1776-1787 (Pubitemid 39330228)
6. Procopio M, Magro G, Cesario F et al (2002) The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19:958-961 (Pubitemid 35356924)
7. Taylor WH, Khaleeli AA (2001) Coincident diabetes mellitus and primary hyperparathyroidism. Diabetes Metab Res Rev 17:175-180 (Pubitemid 32624600)
8. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B (1993) Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197-202 (Pubitemid 23242713)
9. Richards ML, Thompson NW (1999) Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery 126:1160-1166
10. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN (1997) Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serumcalcium concentration and cardiovascular disease mortality. Metabolism 46:1171-1177 (Pubitemid 27418507)
11. Sun G, Vasdev S, Martin GR et al (2005) Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes 54:3336-3339 (Pubitemid 43334392)
12. Hagström E, Hellman P, Lundgren E, Lind L, Arnlöv J (2007) Serum calciumis independently associated with insulin sensitivity measured with euglycaemic-hyperinsulinaemic clamp in a community-based cohort. Diabetologia 50:317-324
13. DeLuca HF (1975) The kidney as an endocrine organ involved in the function of vitamin D. Am J Med 58:39-47
14. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S77-S84
15. Block GA, Port FK (2000) Re?evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendation for a change in management. Am J Kidney Dis 35:1226-1237 (Pubitemid 30354431)
16. Mills WR, Einstadter D, Finkelhor RS (2004) Relation of calcium-phosphorus product to the severity of aortic stenosis in patients with normal renal function. Am J Cardiol 94:1196-1198 (Pubitemid 39424231)
17. Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167:879-885 (Pubitemid 46762749)
18. Tonelli M, Sacks F, Pfeffer M et al (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112:2627-2633 (Pubitemid 41532599)
19. Haap M, Heller E, Thamer C, Tschritter O, Stefan N, Fritsche A (2006) Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. Eur J Clin Nutr 60:734-739 (Pubitemid 43842228)
20. DeFronzo RA, Lang R (1980) Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl JMed 303:1259-1263 (Pubitemid 11194149)
21. Wittmann I, Nagy J (1997) Effectiveness of phosphate supplementation in glucose intolerant, hypophosphatemic patients. Miner Electrolyte Metab 23:62-63 (Pubitemid 27081526)
22. Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study: design, objectives and recruitment results. Ann Epidemiol 5:464-472
23. Herbert V, Lau K, Gottlieb C, Bleicher S (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384
24. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43:52-58 (Pubitemid 27024390)
25. Lott JA, Manning NR, Kyler MK (1989) Proficiency testing in a medical-needs context. Clin Chem 35:347-354 (Pubitemid 19086677)
26. Guynn RW, Veloso D, Veech RL (1972) Enzymic determination of inorganic phosphate in the presence of creatine phosphate. Anal Biochem 45:277-285
27. Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serumcalcium in patients with abnormal serumproteins. BMJ 4:643-646
28. Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137-147
29. Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ (2006) Dairy, magnesium, and calcium intake in relation to insulin sensitivity: approaches to modeling a dose-dependent association. Am J Epidemiol 164:449-458 (Pubitemid 44576612)
30. Harrell FE (2001) Regression modeling strategies. Springer, New York
31. Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760
32. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017-2029 (Pubitemid 46997093)
33. Ko SH, Lee GS, Vo TT (2009) Dietary calcium and 1,25-dihydroxyvitamin D3 regulate transcription of calcium transporter genes in calbindin-D9k knockout mice. J Reprod Dev 55:137-142
34. Resnick LM (1991) Calcium metabolism in hypertension and allied metabolic disorders. Diabetes Care 14:505-520
35. Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S (1988) Relation of serum calcium concentration to metabolic risk factors for cardiovascular disease. BMJ 297:960-963
36. Saltevo J, Niskanen L, Kautiainen H et al (2011) Serum calcium level is associated with metabolic syndrome in the general population: FIN-D2D study. Eur J Endocrinol 165:429-434
37. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S (1997) Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50:967-973 (Pubitemid 27423528)
38. Levy J, Stern Z, Gutman A et al (1986) Plasma calcium and phosphate levels in an adult non-insulin-dependent diabetic population. Calcif Tissue Int 39:316-318 (Pubitemid 16008949)
39. Heath H, Lambert PW, Service FJ et al (1979) Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 49:462-466 (Pubitemid 10188196)
40. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S (2001) Role of apoptosis in pancreatic beta-cell death in diabetes. Diabetes 50(Suppl 1):S44-S447
41. Wang L, Bhattacharjee A, Zuo Z et al (1999) A low voltage-activated Ca2+ current mediates cytokine-induced pancreatic beta-cell death. Endocrinology 140:1200-1204 (Pubitemid 29104221)
42. Ramadan JW, Steiner SR, O'Neill CM, Nunemaker CS (2011) The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 50:481-490
43. Zhou YB, Zhang J, Cai Y et al (2012) Insulin resistance induces medial artery calcification in fructose-fed rats. Exp Biol Med (Maywood) 237:50 -57
44. Ljunghall S, Hedstrand H, Hellsing K, Wibell L (1977) Calcium, phosphate and albumin in serum. A population study with special reference to renal stone formers and the prevalence of hyperparathyroidism in middle-aged men. Acta Med Scand 201:23-30 (Pubitemid 8027092)
45. Lorenzo C, Nath SD, Hanley AJ, Abboud HE, Haffner SM (2008) The relation of low glomerular filtration rate to metabolic disorders in individuals without diabetes and with normoalbuminuria. Clin J Am Soc Nephrol 3:783-789
46. Scragg R (2008) Vitamin D and type 2 diabetes. Are we ready for a prevention trial? Diabetes 57:2565-2566
47. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336-2341 (Pubitemid 41607410)
48. Craver L, Marco MP, Martínez I et al (2007) Mineral metabolism parameters throughout chronic kidney disease stages 1-5: achievement of K/DOQI target ranges. Nephrol Dial Transplant 22:1171-1176 (Pubitemid 46523434)
49. Hsu CY, Chertow GM (2002) Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419-1425
50. Levin A, Bakris GL, Molitch M et al (2006) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31-38 (Pubitemid 44967731)